Download Files:
Idelalisib-d5
SKU
HY-13026S-1 mg
Category Isotope-Labeled Compounds
Tags Autophagy;PI3K, Autophagy;PI3K/Akt/mTOR, Cancer
$420
Only 1000 item(s) left in stock.
Products Details
Product Description
– Idelalisib-d5 is a deuterium labeled Idelalisib. Idelalisib is a highly selective and orally bioavailable p110δ inhibitor[1].
Web ID
– HY-13026S
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C22H13D5FN7O
References
– [1]Lannutti BJ, et al. CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. Blood, 2011, 117(2), 591-594.
CAS Number
– 1830330-31-8
Molecular Weight
– 420.45
Compound Purity
– 98.35
SMILES
– O=C1N(C2=C([2H])C([2H])=C([2H])C([2H])=C2[2H])C([C@@H](NC3=C4N=CNC4=NC=N3)CC)=NC5=C1C(F)=CC=C5
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Autophagy;PI3K
Pathway
– Autophagy;PI3K/Akt/mTOR
Product type
– Isotope-Labeled Compounds
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.